Breaking News Instant updates and real-time market news.

MANH

Manhattan Associates

$59.01

1.105 (1.91%)

17:41
10/18/16
10/18
17:41
10/18/16
17:41

Manhattan Associates ups FY16 adjusted EPS view to $1.82-$1.84 from $1.78-$1.81

Consensus $1.79. Cuts Fy16 revenue view to $603M-$609M from $615M-$620M, consensus $615.98M.

  • 18

    Oct

MANH Manhattan Associates
$59.01

1.105 (1.91%)

07/12/16
RAJA
07/12/16
NO CHANGE
Target $74
RAJA
Outperform
Raymond James a bit more cautious on Manhattan's software license business
Raymond James analyst Terry Tillman has grown a bit more cautious on Manhattan Associates' more volatile software license business and believes Brexit and broader macro concerns could be a temporary headwind in close rates. As a result, Tillman lowered his 2016 software license estimate to 4.5% growth from 7.5% growth and lowered 2016 earnings by a penny to $1.75. The analyst continues to rate Manhattan Associates an Outperform given double digit top-line growth and 20%-30% earnings growth.
07/20/16
BMUR
07/20/16
NO CHANGE
Target $75
BMUR
Buy
Manhattan Associates reports 'typical solid' performance, says Brean Capital
Brean Capital called Manhattan Associates' Q2 results a typical solid performance. The firm said the shares reflect the company's exceptional consistency in its sales execution and could command higher valuation multiples as the company continues to show solid, consistent execution and improving margins. Brean Capital reiterated its Buy rating and $75 price target on Manhattan Associates shares.
08/02/16
BMUR
08/02/16
NO CHANGE
Target $75
BMUR
Buy
Manhattan Associates CFO rehire a positive, says Brean Capital
Brean Capital noted Manhattan Associates rehired Dennis Story as CFO and views it as positive for the company. The firm noted he resigned for family related issues, but he had been a long time member of the executive team and a key contributor to the company's consistent financial performance. Brean Capital reiterated its Buy rating and $75 price target on Manhattan Associates shares.
10/13/16
BMUR
10/13/16
NO CHANGE
Target $75
BMUR
Buy
Manhattan Associates well positioned for solid quarter, says Brean Capital
Brean Capital analyst Yun Kim said checks on the industry fundamentals show a steady positive demand environment. The analyst believes Manhattan Associates remains well positioned to deliver yet another solid quarter including top line growth and improving margin leverage. Kim reiterated his Buy rating and $75 price target on Manhattan Associates shares.

TODAY'S FREE FLY STORIES

WFC

Wells Fargo

$53.36

0.65 (1.23%)

07:10
09/20/17
09/20
07:10
09/20/17
07:10
Periodicals
Wells Fargo general counsel aims to clean up reputation, Reuters reports »

Wells Fargo general…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 12

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

ELY

Callaway Golf

$14.14

0.12 (0.86%)

07:09
09/20/17
09/20
07:09
09/20/17
07:09
Recommendations
Callaway Golf analyst commentary  »

Callaway Golf EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$252.46

-0.62 (-0.24%)

07:09
09/20/17
09/20
07:09
09/20/17
07:09
Recommendations
Boeing analyst commentary  »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

MTCH

Match Group

$23.45

-0.02 (-0.09%)

07:08
09/20/17
09/20
07:08
09/20/17
07:08
Recommendations
Match Group analyst commentary  »

Match Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:08
09/20/17
09/20
07:08
09/20/17
07:08
Hot Stocks
Breaking Hot Stocks news story on General Mills »

General Mills down 4.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

KPTI

Karyopharm

$10.52

-0.34 (-3.13%)

07:07
09/20/17
09/20
07:07
09/20/17
07:07
Hot Stocks
Karyopharm: 'successful' outcome from Phase 2 portion of Phase 2/3 SEAL study »

Karyopharm reported a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:05
09/20/17
09/20
07:05
09/20/17
07:05
Hot Stocks
General Mills CEO says FY18 priority is 'strengthening our topline performance' »

"Our number one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

SNY

Sanofi

$49.10

0.46 (0.95%)

, ALNY

Alnylam

$75.04

-0.96 (-1.26%)

07:05
09/20/17
09/20
07:05
09/20/17
07:05
Hot Stocks
Sanofi and Alnylam report topline results of patisiran in ATTR amyloidosis »

Sanofi's (SNY)…

SNY

Sanofi

$49.10

0.46 (0.95%)

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ADBE

Adobe

$156.60

0.83 (0.53%)

07:04
09/20/17
09/20
07:04
09/20/17
07:04
Recommendations
Adobe analyst commentary  »

Adobe near-term weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

WDC

Western Digital

$89.92

0.74 (0.83%)

07:04
09/20/17
09/20
07:04
09/20/17
07:04
Technical Analysis
Technical View: Western Digital falls as Toshiba selects Bain-led group as buyer »

Toshiba (TOSBF, TOSYY)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:04
09/20/17
09/20
07:04
09/20/17
07:04
Hot Stocks
General Mills CEO says 'confident in improved momentum' for rest of year »

CEO Harmening said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

SIX

Six Flags

$56.75

-0.32 (-0.56%)

07:03
09/20/17
09/20
07:03
09/20/17
07:03
Hot Stocks
Six Flags says no expected material impact from Mexico earthquake »

Six Flags Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

PG

Procter & Gamble

$94.17

1.02 (1.10%)

07:03
09/20/17
09/20
07:03
09/20/17
07:03
Hot Stocks
Procter & Gamble: Peltz 'lacks specific qualities' P&G seeking in board members »

The Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:03
09/20/17
09/20
07:03
09/20/17
07:03
Hot Stocks
General Mills reports Q1 gross margin down 150 bps to 34.8% »

Gross margin decreased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

07:02
09/20/17
09/20
07:02
09/20/17
07:02
General news
MBA Mortgage Applications Composite Index data reported »

Week of 9/15 MBA Mortgage…

IDN

Intellicheck

07:02
09/20/17
09/20
07:02
09/20/17
07:02
Initiation
Intellicheck initiated  »

Intellicheck initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

, SNY

Sanofi

$49.10

0.46 (0.95%)

07:02
09/20/17
09/20
07:02
09/20/17
07:02
Hot Stocks
Alnylam, Sanofi say APOLLO Phase 3 study met primary, secondary endpoints »

Alnylam Pharmaceuticals…

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

SNY

Sanofi

$49.10

0.46 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:02
09/20/17
09/20
07:02
09/20/17
07:02
Earnings
General Mills backs FY18 adjusted EPS growth of 1%-2%, consensus $3.10 »

Reaffirms fiscal 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:00
09/20/17
09/20
07:00
09/20/17
07:00
Earnings
General Mills reports Q1 adjusted EPS 71c, consensus 76c »

Reports Q1 revenue $3.8B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

CELG

Celgene

$143.47

0.63 (0.44%)

, XLRN

Acceleron

$38.97

-0.41 (-1.04%)

06:59
09/20/17
09/20
06:59
09/20/17
06:59
Recommendations
Celgene, Acceleron analyst commentary  »

Jefferies sees Celgene…

CELG

Celgene

$143.47

0.63 (0.44%)

XLRN

Acceleron

$38.97

-0.41 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 21

    Sep

ACH

Aluminum Corp. of China

$21.31

0.28 (1.33%)

06:59
09/20/17
09/20
06:59
09/20/17
06:59
Technical Analysis
Technical View: Aluminum Corp. of China at new 52-week high in pre-market »

The stock was last…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$94.87

0.49 (0.52%)

06:58
09/20/17
09/20
06:58
09/20/17
06:58
Periodicals
Equifax may be able to spend $1 per customer over data breach, Bloomberg says »

Equifax may be able to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

NBY

NovaBay

$4.45

0.1 (2.30%)

06:54
09/20/17
09/20
06:54
09/20/17
06:54
Hot Stocks
NovaBay receives noncompliance notification from NYSE »

NovaBay Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$156.60

0.83 (0.53%)

06:54
09/20/17
09/20
06:54
09/20/17
06:54
Recommendations
Adobe analyst commentary  »

Jefferies ups Adobe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PZRX

PhaseRx

$0.78

0.055 (7.64%)

06:53
09/20/17
09/20
06:53
09/20/17
06:53
Hot Stocks
PhaseRx argininosuccinate lyase deficiency treatment granted FDA orphan status »

PhaseRx's treatment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.